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Abstract  
BACKGROUND: Vitiligo is a chronic skin disorder. White macules caused by melanocyte destruction is a 
characteristic finding that cosmetically disturbing. Until recently, pathogenesis of vitiligo is still unclear. The role of 
homocysteine in vitiligo is mentioned in previous studies thus it is probable that it can be a biomarker to determine 
vitiligo severity.  
AIM: To determine correlation between serum homocysteine and vitiligo area Scoring Index (VASI) 
SUBJECT AND METHOD: This was a cross-sectional analytic study which involved 30 vitiligo patients that were 
diagnosed by clinical and Wood’s lamp examinations then VASI score was determined and same numbers of 
control. We conducted blood sampling and measurement of serum homocysteine level to the patients. 
RESULTS: There is no significant correlation between serum homocysteine and VASI score (p = 0.133, r = 
0.281), family history (p = 0.706), and duration of vitiligo (p = 0.993, r = 0.002). There is no significant difference 
between serum homocysteine in vitiligo patients and controls (p = 0.905). There is a correlation between serum 
homocysteine with gender (p = 0.001) and age (p = 0.036; r = 0.385) in vitiligo patient.  
CONCLUSION: There is no significant correlation between serum homocysteine and VASI score, family history, 
and duration of vitiligo. There is no significant difference between serum homocysteine in vitiligo patients and 
controls. There is a correlation between serum homocysteine with gender and age in vitiligo patient. 
 
 
 
 
 
Introduction 
 
Vitiligo is a skin depigmentation disorder with 
the characteristic as a white macule caused by 
melanocyte destruction. Aetiology of vitiligo is still 
unknown. But there are several hypotheses like 
genetic, autoimmune and biochemistry [1-3].
 
This 
hypothesis was thought to simultaneously work 
together and caused vitiligo. Genetic predisposition 
can trigger autoimmune process, and with the addition 
of oxidative stress, elevation can result in the 
destruction of melanocyte, therefore, inducing white 
macule in vitiligo subjects [4].
  
One compound thought to be involved in this 
hypothesis is homocysteine [5]. Homocysteine-
mediated melanocyte destruction via production of 
interleukin-6 (IL-6), activating nuclear factor-kappa B 
(NF-ĸB) and increased oxidative stress [6]. 
 
Subjects and Methods 
 
This was a cross-sectional analytic study 
involving 30 vitiligo patients and 30 controls who were 
18 years old or above and submitted to the outpatient 
dermatology and venereology clinic in Haji Adam 
Malik General hospital, Medan, North Sumatera, 
Indonesia. This study conducted from June until 
October 2016. Each subject signed informed consent 
were included in this study. Exclusion criteria were 
consumption of vitamin B6, B12, and folic acid within 
the last 6 months, breastfeeding, pregnancy, and 
vitiligo treatment during the last 6 months. Ethical 
clearance was given by Health Research Ethical 
Committee, Faculty of Medicine, University of 
Sumatera Utara.  
All subjects with vitiligo were diagnosed by 
clinical and Wood’s lamp examinations. VASI score 
was determined by calculating body part involved and 
depigmentation severity. VASI was calculated using a 
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formula that includes contributions from all body 
regions (possible range, 0–100). VASI = ∑ Hand Units 
of all body sites × Residual Depigmentation. One 
hand unit, which encompasses the palm plus the volar 
surface of all the digits, is approximately 1% of the 
total body surface area. It is used as a guide to 
estimate the baseline percentage of vitiligo 
involvement in each body region. The body was 
divided into separate regions: upper extremities 
(excluding hands), hands, trunk, lower extremities 
(excluding feet), feet and head and neck. The axillary 
region was included with the upper extremities while 
the buttocks and inguinal areas were included with the 
lower extremities. 
The extent of residual depigmentation was 
expressed by the following percentages: 0, 10%, 25%, 
50%, 75%, 90%, or 100%. At 100% depigmentation; 
no pigment was present, at 90%; specks of pigment 
were present, at 75%; the depigmented area 
exceeded the pigmented area, at 50%; the 
depigmented and pigmented areas were equal, at 
25%; the pigmented area exceeded the depigmented 
area, at 10%; only specks of depigmentation were 
present. 
Fasting blood sample from subjects then 
processed into the serum. Homocysteine level was 
measured from serum by using ADVIA Centaur HCY
®
. 
The results were analysed with SPSS version 
19. Quantitative data were analysed using mean and 
SD. The Student t-test was used to compare the 
means of different groups. Spearman test was used to 
determine relationships. P values less than 0.05 were 
considered significant. 
 
 
Results 
 
There is no significant correlation between 
serum homocysteine and VASI score (p = 0.133, r = 
0.281), family history (p = 0.706), and duration of 
vitiligo (p = 0.993, r = 0.002).  
Table 1: Serum homocysteine level in vitiligo subjects and 
controls 
Subjects Serum homocysteine level 
Mean (µmol/L) Standard Deviation 
(µmol/L) 
p 
Vitiligo 10.66 2.89 0.905 
Control 10.58 2.01 
Male 13.02 1.48 0.001 
Female 9.81 2.81 
Positive family history 11.07 2.16 0.706 
Negative family history 10.56 3.08 
 
There is a correlation between serum 
homocysteine with gender (p = 0.001) and age (p = 
0.036; r = 0.385) in vitiligo patient. There is no 
significant difference between serum homocysteine in 
vitiligo patients and controls (p = 0.905). 
Table 2: Correlation between the serum homocysteine with 
VASI score and other variables 
 p r 
Serum homocysteine with VASI score 0.133 0.281 
Serum homocysteine with age of vitiligo subjects 0.036 0.385 
Serum homocysteine serum with duration of disease 0.993 0.002 
 
 
Discussion 
 
In this study we didn’t find any significant 
correlation between serum homocysteine level and 
VASI score (p > 0.05; r = 0.281). This is in agreement 
with another study in Dr M. Djamil Padang, which 
conducted a study with 17 samples (r = 0.061; p > 
0.05) [7].
 
 
 A similar finding by Zaki et al. in Egypt also 
didn’t find any significant relation between serum 
homocysteine level and VASI score (p > 0.05). Zaki et 
al. reveal this study used VASI score instead of rules 
of nine like in other studies. VASI score evaluates 
vitiligo lesion both quantitatively and qualitatively [8].
 
This result was in disagreement with El-
Dawela and Abou-elf touch who conducted a study 
with 70 samples and found a correlation between 
VASI score and homocysteine serum (r = 0.835, p = 
0.001) with mean VASI score was 9.5 ± 19.5 [9]. 
Similar findings found by Agarwal et al in India with 50 
vitiligo subjects (r = 0.567; p = 0.000). In this study 
VASI score ≥ 30 significantly higher than VASI score 
<30 (p = 0.001) [6]. Sabry et al. in an outpatient clinic 
in Benha University Hospital, Egypt with 35 subjects 
found serum homocysteine level and the extent of 
vitiligo (p = 0.001; r = 0.559). In this study vitiligo 
extent assessed using rules of nine [10]. 
Until now, it is still unclear about the 
underlying pathogenesis of vitiligo. Homocysteine was 
one compound thought to be involved in vitiligo. 
Homocysteine can induce oxidative damage, 
producing IL-6 and activating NF-ĸB which results in 
melanocyte destruction. IL-6 can increase the 
expression of intercellular adhesion molecule-1 that 
will stimulate adhesion melanocyte to leucocyte, 
inducing activation of polyclonal B cell and increasing 
production of autoantibody [11].
 
Activation of NF-KB 
by homocysteine then modulate expression of pro- 
apoptotic p53 in v it i l igo les ion [12] . All of these 
could damage melanocyte [11, 12]. 
 Other than that homocysteine also can 
produce oxidative stress, accumulate melanocytotoxic 
compound and inhibit natural detoxification which 
contributing in melanocyte destruction. Homocysteine 
can also affect tyrosinase in melanin synthesis at 
enzyme’s active location. Free homocysteine also can 
react nonenzymatically with sulfhydryl and thiolation 
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can also occur. Both of which can affect the function 
of enzyme and protein [10, 13, 14].
 
In this study, there is no significant difference 
of serum homocysteine in vitiligo and control (p = 
0.905). Factors affecting homocysteine are genetic, 
blood vitamin, sex, age, life style, drugs, 
hyperproliferating disease, renal failure, heart failure 
and diabetes mellitus [5, 15]. A similar finding was 
found by Zaki et al. who didn’t find any difference 
between vitiligo subjects and control (p = 0.191) [8].
 
 In disagreement, Singh et al at Sir Sunderhal 
Hospital, Varanasi, India with 200 vitiligo subjects and 
75 controls found homocysteine level was significantly 
higher than control [16]. El-Dawela, Abou-elfetouh, 
Sabry and Agarwal found similar results [6, 9].
 
 In conclusion, there is no significant 
correlation between serum homocysteine and VASI 
score, family history, and duration of vitiligo. There is 
no significant difference between serum homocysteine 
in vitiligo patients and controls. There is a correlation 
between serum homocysteine with gender and age in 
vitiligo patient. Further study needed to determine the 
pathogenesis of vitiligo and whether homocysteine 
had an influence on that. 
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